Skip to main content
TDOC
NYSE Industrial Applications And Services

Teladoc Health Q2 2026: BetterHelp Cash-Pay Collapse Accelerates, Forcing Guidance Cut and Liquidity Scrutiny

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$6.775
Mkt Cap
$1.223B
52W Low
$4.4
52W High
$9.887
52W Position info
54% above low
Off High info
31% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

TDOC sits 54% above its 52-week low of $4.4.

Summary

Teladoc Health's Q2 2026 10-Q shows BetterHelp's cash-pay revenue decline accelerated beyond expectations, with insurance-covered services unable to offset the drop due to provider capacity constraints. The company slashed BetterHelp's full-year outlook, and the $1 billion convertible note maturity now looms as a current liability, intensifying liquidity concerns.


Key Events · Earnings and Guidance · TDOC

  • BetterHelp Cash-Pay Revenue Decline Accelerates

    In May 2026, the rate of decline in BetterHelp's cash-pay revenue accelerated beyond prior assumptions, and the trend proved more persistent and significant than expected. Consumer and Other revenue fell 20% YoY to $190.9M in Q2, while Insurance Covered Services grew to $21.8M but could not offset the drop.

  • Insurance Pivot Constrained by Provider Capacity

    Demand for insurance-covered therapy exceeded the available capacity of credentialed, enrolled, and active providers. Insurance-specific workflows for eligibility, matching, and scheduling limited conversion of demand into paying users and revenue, forcing a reduction in advertising spend to align with capacity.

  • Full-Year BetterHelp Outlook Materially Reduced

    Management now expects fewer total BetterHelp paying users and lower BetterHelp revenue for 2026 than previously anticipated, citing the persistent cash-pay decline and operational constraints in scaling insurance-covered services.

  • $1B Convertible Notes Reclassified as Current Liability

    The 2027 Notes ($1.0B principal, due June 1, 2027) are now classified as a current liability of $996.7M, highlighting refinancing risk. The company has $774.3M in cash and an undrawn $300M revolver, but free cash flow fell to $9.4M in H1 2026 from $45.5M a year ago.


Analysis · TDOC · Industrial Applications And Services

Teladoc Health's Q2 2026 10-Q reveals that the decline in BetterHelp's cash-pay business accelerated sharply in May, far exceeding prior expectations. The shift to insurance-covered services is not offsetting the drop because provider capacity and platform workflows cannot convert the surge in demand into paying users and revenue. Management has materially reduced BetterHelp's full-year outlook and cut advertising spend to align with capacity, which will further pressure user acquisition. The $1 billion convertible note maturity in June 2027 is now classified as a current liability, putting a spotlight on the company's liquidity runway. While the company has $774 million in cash and an undrawn $300 million revolver, free cash flow has dwindled to $9.4 million in the first half, raising questions about its ability to refinance or repay the notes without dilutive actions. The 10-Q also flags a goodwill impairment risk for BetterHelp, though no charge was taken this quarter. This filing confirms that the core direct-to-consumer mental health business is deteriorating faster than the market anticipated, and the pivot to insurance is proving operationally challenging.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TDOC was trading at $6.78 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $4.40 to $9.89. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TDOC - Latest Insights

TDOC
Jul 29, 2026, 5:00 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $7.45
Real-time Price: $5.56 info
Change: -$1.89 (-25%) info
Market Cap: $1.003B info
TDOC
Jul 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.01
Real-time Price: $5.56 info
Change: -$1.45 (-21%) info
Market Cap: $1.003B info
TDOC
Jul 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $7.36
Real-time Price: $5.56 info
Change: -$1.80 (-24%) info
Market Cap: $1.003B info
TDOC
Apr 30, 2026, 10:21 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.39
Real-time Price: $5.56 info
Change: +$0.170 (+3%) info
Market Cap: $1.003B info
TDOC
Apr 29, 2026, 4:53 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.64
Real-time Price: $5.56 info
Change: -$0.080 (-1%) info
Market Cap: $1.003B info